Tumor-associated calcium signal transducer 2 (Trop2) is a protein in humans is encoded by the TACSTD2 gene. Trop2 was first discovered in trophoblast cells. It is a transmembrane type-1 glycoprotein expressed in multistratified epithelia and several stem/progenitor and carcinoma cells. Trop2 could form an analogous dimer. The incomplete or aberrant production of Trop2 may cause it to lose its function and to be internalized from the membrane into the cytoplasm, where it plays a role in cancer progression. Due to elevated expression levels in carcinoma cells vs. normal tissue, Trop2 has clinical potential both for cancer prognosis and immunotherapy.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy product with the complete TCR complex without HLA matching dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE